Cardiff Oncology Inc (CRDF)

04:42 AM

Cardiff Pushes Towards Colorectal Cancer Phase III As Funding Questions Loom - insights.citeline.com

04:42 AM

Aug 03, 2025

How does Cardiff Oncology Inc. generate profit in a changing economyAchieve breakthrough gains with smart trades - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the dividend policy of Cardiff Oncology Inc. stockGet real-time alerts on top stocks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Why is Cardiff Oncology Inc. stock attracting strong analyst attentionFree Popular Stock Recommendations - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Cardiff Oncology Inc. stock in 2025Maximize returns with disciplined investment techniques - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Cardiff Oncology Inc. stockUnstoppable profit momentum - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Cardiff Oncology Inc. stock overvalued or undervaluedMarket-crushing stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Cardiff Oncology Inc. company’s balance sheetFree Risk Assessment Services - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What analysts say about Cardiff Oncology Inc. stockGrow your wealth with proven stock picks - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What drives Cardiff Oncology Inc. stock priceUnrivaled growth potential - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What is the risk reward ratio of investing in Cardiff Oncology Inc. stockAchieve consistent profits with proven methods - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What catalysts could drive Cardiff Oncology Inc. stock higher in 2025Free Investment Risk Control - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Is Cardiff Oncology Inc. a good long term investmentHigh-return market picks - Jammu Links News

Aug 02, 2025

Aug 02, 2025

When is Cardiff Oncology Inc. stock expected to show significant growthSuperior returns - Jammu Links News

Aug 02, 2025

Aug 02, 2025

Is Cardiff Oncology Inc. a growth stock or a value stockNavigate the market with precision tools - Jammu Links News

Aug 02, 2025

Jul 31, 2025

Both Individual Investors Who Control a Good Portion of Cardiff Oncology, Inc. (NASDAQ:CRDF) Along With Institutions Must Be Dismayed After Last Week's 42% Decrease - 富途牛牛

Jul 31, 2025

Jul 30, 2025

Why Is Cardiff Oncology Stock Trading Lower After Colorectal Cancer Data? - inkl

Jul 30, 2025

Jul 30, 2025

Cardiff Oncology Insiders Land Bargain With Gains Of US$244k - Yahoo Finance

Jul 30, 2025

Jul 30, 2025

Cardiff Oncology: Data Update Resolves Some Signals - Seeking Alpha

Jul 30, 2025

Jul 30, 2025

Cardiff Oncology (CRDF.O) Plummets 27%: What's Behind the Sharp Intraday Move? - AInvest

Jul 30, 2025

Jul 30, 2025

Avis Budget Group Posts Downbeat Earnings, Joins SoFi Technologies, Seagate And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Jul 30, 2025

Jul 30, 2025

Cardiff Oncology Shares Slide Over 26% In Premarket Trading After Mixed Q2 - Benzinga

Jul 30, 2025

Jul 30, 2025

Cardiff Oncology Plunges 26.59% on Earnings Miss - AInvest

Jul 30, 2025

Jul 30, 2025

Cardiff Oncology 2025 Q2 Earnings Financial Struggles as Net Income Declines 18.4% - AInvest

Jul 30, 2025

Jul 30, 2025

Cardiff Oncology Reports Q2 2025 Financial Results - TipRanks

Jul 30, 2025

Jul 29, 2025

Cardiff Oncology shares fall 26.89% after-hours after reporting a wider Q2 net loss. - AInvest

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology shares plunge after Q2 earnings miss By Investing.com - Investing.com South Africa

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology shares plunge after Q2 earnings miss - Investing.com Australia

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology: Q2 Earnings Snapshot - San Francisco Chronicle

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology earnings missed by $0.02, revenue topped estimates - Investing.com

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology reports results from colorectal cancer trial - Seeking Alpha

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology reports positive data from colorectal cancer trial By Investing.com - Investing.com Nigeria

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology reports positive data from colorectal cancer trial - Investing.com Australia

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology Announces Positive Data from Ongoing Randomized - GuruFocus

Jul 29, 2025

Jul 29, 2025

Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update - GlobeNewswire

Jul 29, 2025

Jul 29, 2025

Breakthrough: New Cancer Drug Achieves 49% Response Rate vs 30% Standard Care in Colorectal Cancer Trial - Stock Titan

Jul 29, 2025

Jul 29, 2025

Clinical Trial Success: Cardiff Oncology Advances Colorectal Cancer Treatment with 40% Response Rate - Stock Titan

Jul 29, 2025

Jul 29, 2025

How Cardiff Oncology Inc. stock performs during market volatilityOversold Stock Bounce Playbook Generator - Newser

Jul 29, 2025

Jul 29, 2025

Is Cardiff Oncology Inc. stock a growth or value playFree Growth Based Stock Signal Screener - Newser

Jul 29, 2025

Jul 29, 2025

Is Cardiff Oncology Inc. Stock Overbought or Oversold RSI Indicator AnalysisReal Trader Watchlist with Entry Targets - Newser

Jul 29, 2025

Jul 28, 2025

Pancreatic Ductal Adenocarcinoma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Cardiff Oncology, XOMA, Alphamab, Cantargia, RenovoRx, Syntrix - Barchart.com

Jul 28, 2025

Jul 28, 2025

How volatile is Cardiff Oncology Inc. stock compared to the marketGet alerts on the hottest market movers - Jammu Links News

Jul 28, 2025